Sandrine Happi
Nurse Practitioner · Takoma Park, MDNPI 1619468162
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 310 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $2,779 and has fallen 97.5% since, to $70 in 2025. Among nurse practitioner clinicians in MD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 310 payments — averaging $16.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$1K
- AbbVie$832
- Lilly USA, LLC$491
- Corcept Therapeutics$422
- Amarin Pharma, Inc.$325
- Pfizer$251
- plus $2K from 23 others
What the payments were for
- Food & beverage$5,228100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 75 | $1,104 |
| AbbVie | 54 | $832 |
| Lilly USA, LLC | 36 | $491 |
| Corcept Therapeutics | 21 | $422 |
| Amarin Pharma, Inc. | 23 | $325 |
| Pfizer | 15 | $251 |
| Amgen | 11 | $223 |
| Boehringer Ingelheim | 11 | $214 |
| Abbott | 9 | $195 |
| E.r. Squibb & Sons, L.L.C. | 4 | $155 |
| Johnson & Johnson | 6 | $136 |
| AstraZeneca | 6 | $103 |
| Arbor Pharmaceuticals, Inc. | 5 | $97 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $87 |
| Viiv Healthcare Company | 4 | $73 |
| Merck | 3 | $68 |
| Novartis | 4 | $68 |
| Sanofi-aventis U.S. LLC | 3 | $63 |
| Exact Sciences | 3 | $58 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $49 |
| Bayer | 2 | $36 |
| Scilex Pharmaceuticals Inc. | 2 | $34 |
| Dynavax Technologies Corporation | 1 | $31 |
| Kowa Pharmaceuticals America, Inc. | 2 | $29 |
| Antares Pharma, Inc. | 1 | $21 |
| GSK | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $17 |
| Dexcom, Inc. | 1 | $16 |
| Alfasigma USA, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,228 in reported general payments places this provider in the 95th percentile of 1,562 nurse practitioner providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 17 | $72 |
| Losartan Potassium | 12 | $62 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Takoma Park
- Morgan GaleRockville$292K
- Sherilyn BrinkleyBaltimore$100K
- Michelle TurnerBaltimore$94K
- Nelli ZafmanLutherville$67K
- Ellen LancasterFallston$52K
- Doris TateEaston$34K
- Zeev NemirovskyBaltimore$19K
- Martha ReilleyAnnapolis$18K
- Stephanie ZwonitzerAnnapolis$16K
- Jennifer MaglianoTimonium$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.